Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients
Identifieur interne : 002526 ( Ncbi/Merge ); précédent : 002525; suivant : 002527Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients
Auteurs : Khalid A. Alburikan [Arabie saoudite] ; Hatem A. Abuelizz [Arabie saoudite]Source :
- Saudi Pharmaceutical Journal : SPJ [ 1319-0164 ] ; 2019.
Abstract
Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia. It is associated with significant mortality and morbidity. We identified factors associated with the Middle East Respiratory Syndrome-Coronavirus (MERS‐CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection or exposure to the virus. We also looked at the impact of medication history on virus transmission.
We included subjects with suspected MERS-CoV infection and confirmed cases of MERS infection. Subjects were excluded if there were any missing data that prevent the final analysis. Descriptive statistics were used to report demographic data. Percentages and frequencies were used to summarize the categorical variables, while means and standard deviations were calculated for continuous variables. Logistic regression was used to assess the risk of MERS-CoV infection among the suspected cases. A value of
A total of 16,189 suspected cases were identified, complete data were analyzed for 3154 to assess factors that are independently associated with MERS-CoV infection. MERS-CoV infection was associated with age (adjusted odds ratio [AOR] = 1.06; 95% CI [1.02–1.098], P-value = 0.004), male gender (AOR = 1.617; 95% CI [1.365–1.77], P-value < 0.001) and diabetes (AOR = 1.68; 95% CI [1.346–1.848], P-value = 0.002. There was no significant association with the other comorbidities. Medication history was not associated with an increase or decrease the likelihood of the infection.
MERS-Cov infection is more common in male, advanced age and diabetes. No medications were associated with an increase or decrease the likelihood of the infection. This is important to focus on screening and detection to this patient population.
Url:
DOI: 10.1016/j.jsps.2019.11.016
PubMed: 32042254
PubMed Central: 7000305
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 001139
- to stream Pmc, to step Curation: 001139
- to stream Pmc, to step Checkpoint: 000278
- to stream PubMed, to step Corpus: 000243
- to stream PubMed, to step Curation: 000243
- to stream PubMed, to step Checkpoint: 000179
Links to Exploration step
PMC:7000305Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients</title><author><name sortKey="Alburikan, Khalid A" sort="Alburikan, Khalid A" uniqKey="Alburikan K" first="Khalid A." last="Alburikan">Khalid A. Alburikan</name><affiliation wicri:level="1"><nlm:aff id="af005">Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author><author><name sortKey="Abuelizz, Hatem A" sort="Abuelizz, Hatem A" uniqKey="Abuelizz H" first="Hatem A." last="Abuelizz">Hatem A. Abuelizz</name><affiliation wicri:level="1"><nlm:aff id="af010">Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32042254</idno><idno type="pmc">7000305</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000305</idno><idno type="RBID">PMC:7000305</idno><idno type="doi">10.1016/j.jsps.2019.11.016</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">001139</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001139</idno><idno type="wicri:Area/Pmc/Curation">001139</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001139</idno><idno type="wicri:Area/Pmc/Checkpoint">000278</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000278</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:32042254</idno><idno type="wicri:Area/PubMed/Corpus">000243</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000243</idno><idno type="wicri:Area/PubMed/Curation">000243</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000243</idno><idno type="wicri:Area/PubMed/Checkpoint">000179</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000179</idno><idno type="wicri:Area/Ncbi/Merge">002526</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients</title><author><name sortKey="Alburikan, Khalid A" sort="Alburikan, Khalid A" uniqKey="Alburikan K" first="Khalid A." last="Alburikan">Khalid A. Alburikan</name><affiliation wicri:level="1"><nlm:aff id="af005">Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author><author><name sortKey="Abuelizz, Hatem A" sort="Abuelizz, Hatem A" uniqKey="Abuelizz H" first="Hatem A." last="Abuelizz">Hatem A. Abuelizz</name><affiliation wicri:level="1"><nlm:aff id="af010">Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author></analytic><series><title level="j">Saudi Pharmaceutical Journal : SPJ</title><idno type="ISSN">1319-0164</idno><idno type="eISSN">2213-7475</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia. It is associated with significant mortality and morbidity. We identified factors associated with the Middle East Respiratory Syndrome-Coronavirus (MERS‐CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection or exposure to the virus. We also looked at the impact of medication history on virus transmission.</p></sec><sec><title>Method</title><p>We included subjects with suspected MERS-CoV infection and confirmed cases of MERS infection. Subjects were excluded if there were any missing data that prevent the final analysis. Descriptive statistics were used to report demographic data. Percentages and frequencies were used to summarize the categorical variables, while means and standard deviations were calculated for continuous variables. Logistic regression was used to assess the risk of MERS-CoV infection among the suspected cases. A value of <italic>p</italic> < 0.05 was considered statistically significant.</p></sec><sec><title>Results</title><p>A total of 16,189 suspected cases were identified, complete data were analyzed for 3154 to assess factors that are independently associated with MERS-CoV infection. MERS-CoV infection was associated with age (adjusted odds ratio [AOR] = 1.06; 95% CI [1.02–1.098], P-value = 0.004), male gender (AOR = 1.617; 95% CI [1.365–1.77], P-value < 0.001) and diabetes (AOR = 1.68; 95% CI [1.346–1.848], P-value = 0.002. There was no significant association with the other comorbidities. Medication history was not associated with an increase or decrease the likelihood of the infection.</p></sec><sec><title>Conclusions</title><p>MERS-Cov infection is more common in male, advanced age and diabetes. No medications were associated with an increase or decrease the likelihood of the infection. This is important to focus on screening and detection to this patient population.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Aleanizy, Fadilah Sfouq" uniqKey="Aleanizy F">Fadilah Sfouq Aleanizy</name></author><author><name sortKey="Mohmed, Nahla" uniqKey="Mohmed N">Nahla Mohmed</name></author><author><name sortKey="Alqahtani, Fulwah Y" uniqKey="Alqahtani F">Fulwah Y. Alqahtani</name></author><author><name sortKey="Mohamed, Rania Ali El Hadi" uniqKey="Mohamed R">Rania Ali El Hadi Mohamed</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Assiri, Abdullah" uniqKey="Assiri A">Abdullah Assiri</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chan, Jasper F W" uniqKey="Chan J">Jasper F.W. Chan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, Xin" uniqKey="Chen X">Xin Chen</name></author><author><name sortKey="Chughtai, Abrar Ahmad" uniqKey="Chughtai A">Abrar Ahmad Chughtai</name></author><author><name sortKey="Dyda, Amalie" uniqKey="Dyda A">Amalie Dyda</name></author><author><name sortKey="Macintyre, Chandini Raina" uniqKey="Macintyre C">Chandini Raina MacIntyre</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cotten, Matthew" uniqKey="Cotten M">Matthew Cotten</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Groot, R J" uniqKey="De Groot R">R.J. de Groot</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Guery, Benoit" uniqKey="Guery B">Benoit Guery</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Raj, V Stalin" uniqKey="Raj V">V. Stalin Raj</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rivers, Caitlin M" uniqKey="Rivers C">Caitlin M. Rivers</name></author><author><name sortKey="Majumder, Maimuna S" uniqKey="Majumder M">Maimuna S. Majumder</name></author><author><name sortKey="Lofgren, Eric T" uniqKey="Lofgren E">Eric T. Lofgren</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zumla, Alimuddin" uniqKey="Zumla A">Alimuddin Zumla</name></author><author><name sortKey="Hui, David S" uniqKey="Hui D">David S Hui</name></author><author><name sortKey="Perlman, Stanley" uniqKey="Perlman S">Stanley Perlman</name></author></analytic></biblStruct></listBibl></div1></back></TEI><double pmid="32042254"><pmc><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients</title><author><name sortKey="Alburikan, Khalid A" sort="Alburikan, Khalid A" uniqKey="Alburikan K" first="Khalid A." last="Alburikan">Khalid A. Alburikan</name><affiliation wicri:level="1"><nlm:aff id="af005">Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author><author><name sortKey="Abuelizz, Hatem A" sort="Abuelizz, Hatem A" uniqKey="Abuelizz H" first="Hatem A." last="Abuelizz">Hatem A. Abuelizz</name><affiliation wicri:level="1"><nlm:aff id="af010">Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32042254</idno><idno type="pmc">7000305</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000305</idno><idno type="RBID">PMC:7000305</idno><idno type="doi">10.1016/j.jsps.2019.11.016</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">001139</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001139</idno><idno type="wicri:Area/Pmc/Curation">001139</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001139</idno><idno type="wicri:Area/Pmc/Checkpoint">000278</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000278</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients</title><author><name sortKey="Alburikan, Khalid A" sort="Alburikan, Khalid A" uniqKey="Alburikan K" first="Khalid A." last="Alburikan">Khalid A. Alburikan</name><affiliation wicri:level="1"><nlm:aff id="af005">Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author><author><name sortKey="Abuelizz, Hatem A" sort="Abuelizz, Hatem A" uniqKey="Abuelizz H" first="Hatem A." last="Abuelizz">Hatem A. Abuelizz</name><affiliation wicri:level="1"><nlm:aff id="af010">Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia</nlm:aff><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author></analytic><series><title level="j">Saudi Pharmaceutical Journal : SPJ</title><idno type="ISSN">1319-0164</idno><idno type="eISSN">2213-7475</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia. It is associated with significant mortality and morbidity. We identified factors associated with the Middle East Respiratory Syndrome-Coronavirus (MERS‐CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection or exposure to the virus. We also looked at the impact of medication history on virus transmission.</p></sec><sec><title>Method</title><p>We included subjects with suspected MERS-CoV infection and confirmed cases of MERS infection. Subjects were excluded if there were any missing data that prevent the final analysis. Descriptive statistics were used to report demographic data. Percentages and frequencies were used to summarize the categorical variables, while means and standard deviations were calculated for continuous variables. Logistic regression was used to assess the risk of MERS-CoV infection among the suspected cases. A value of <italic>p</italic> < 0.05 was considered statistically significant.</p></sec><sec><title>Results</title><p>A total of 16,189 suspected cases were identified, complete data were analyzed for 3154 to assess factors that are independently associated with MERS-CoV infection. MERS-CoV infection was associated with age (adjusted odds ratio [AOR] = 1.06; 95% CI [1.02–1.098], P-value = 0.004), male gender (AOR = 1.617; 95% CI [1.365–1.77], P-value < 0.001) and diabetes (AOR = 1.68; 95% CI [1.346–1.848], P-value = 0.002. There was no significant association with the other comorbidities. Medication history was not associated with an increase or decrease the likelihood of the infection.</p></sec><sec><title>Conclusions</title><p>MERS-Cov infection is more common in male, advanced age and diabetes. No medications were associated with an increase or decrease the likelihood of the infection. This is important to focus on screening and detection to this patient population.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Aleanizy, Fadilah Sfouq" uniqKey="Aleanizy F">Fadilah Sfouq Aleanizy</name></author><author><name sortKey="Mohmed, Nahla" uniqKey="Mohmed N">Nahla Mohmed</name></author><author><name sortKey="Alqahtani, Fulwah Y" uniqKey="Alqahtani F">Fulwah Y. Alqahtani</name></author><author><name sortKey="Mohamed, Rania Ali El Hadi" uniqKey="Mohamed R">Rania Ali El Hadi Mohamed</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Assiri, Abdullah" uniqKey="Assiri A">Abdullah Assiri</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chan, Jasper F W" uniqKey="Chan J">Jasper F.W. Chan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, Xin" uniqKey="Chen X">Xin Chen</name></author><author><name sortKey="Chughtai, Abrar Ahmad" uniqKey="Chughtai A">Abrar Ahmad Chughtai</name></author><author><name sortKey="Dyda, Amalie" uniqKey="Dyda A">Amalie Dyda</name></author><author><name sortKey="Macintyre, Chandini Raina" uniqKey="Macintyre C">Chandini Raina MacIntyre</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cotten, Matthew" uniqKey="Cotten M">Matthew Cotten</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Groot, R J" uniqKey="De Groot R">R.J. de Groot</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Guery, Benoit" uniqKey="Guery B">Benoit Guery</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Raj, V Stalin" uniqKey="Raj V">V. Stalin Raj</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rivers, Caitlin M" uniqKey="Rivers C">Caitlin M. Rivers</name></author><author><name sortKey="Majumder, Maimuna S" uniqKey="Majumder M">Maimuna S. Majumder</name></author><author><name sortKey="Lofgren, Eric T" uniqKey="Lofgren E">Eric T. Lofgren</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zumla, Alimuddin" uniqKey="Zumla A">Alimuddin Zumla</name></author><author><name sortKey="Hui, David S" uniqKey="Hui D">David S Hui</name></author><author><name sortKey="Perlman, Stanley" uniqKey="Perlman S">Stanley Perlman</name></author></analytic></biblStruct></listBibl></div1></back></TEI></pmc><pubmed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients.</title><author><name sortKey="Alburikan, Khalid A" sort="Alburikan, Khalid A" uniqKey="Alburikan K" first="Khalid A" last="Alburikan">Khalid A. Alburikan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author><author><name sortKey="Abuelizz, Hatem A" sort="Abuelizz, Hatem A" uniqKey="Abuelizz H" first="Hatem A" last="Abuelizz">Hatem A. Abuelizz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32042254</idno><idno type="pmid">32042254</idno><idno type="doi">10.1016/j.jsps.2019.11.016</idno><idno type="wicri:Area/PubMed/Corpus">000243</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000243</idno><idno type="wicri:Area/PubMed/Curation">000243</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000243</idno><idno type="wicri:Area/PubMed/Checkpoint">000179</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000179</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients.</title><author><name sortKey="Alburikan, Khalid A" sort="Alburikan, Khalid A" uniqKey="Alburikan K" first="Khalid A" last="Alburikan">Khalid A. Alburikan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Clincal Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author><author><name sortKey="Abuelizz, Hatem A" sort="Abuelizz, Hatem A" uniqKey="Abuelizz H" first="Hatem A" last="Abuelizz">Hatem A. Abuelizz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451</wicri:regionArea><wicri:noRegion>Riyadh 11451</wicri:noRegion></affiliation></author></analytic><series><title level="j">Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society</title><idno type="ISSN">1319-0164</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia. It is associated with significant mortality and morbidity. We identified factors associated with the Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) infection among suspected cases presented with sign and symptoms of upper respiratory infection or exposure to the virus. We also looked at the impact of medication history on virus transmission.</div></front></TEI></pubmed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002526 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002526 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:7000305
|texte= Identifying factors and target preventive therapies for Middle East Respiratory Syndrome sucsibtable patients
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32042254" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |